Lab Corp. (LH) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
LabCorp (LH) PT Raised to $155 at Evercore ISI
July 27, 2016 11:57 AM EDTEvercore ISI analyst Ross Muken reiterated a Buy rating and boosted his price target on Laboratory Corporation of America (NYSE: LH) to $155.00 (from $147.00) following results and the Sequenom deal.
Muken commented, "While the quarter did not go exactly as we had envisioned (notable CVD beat + better rev/req didnt yield as... More
LabCorp (LH) to Acquire Sequenom (SQNM) for $302M
July 27, 2016 7:00 AM EDTLaboratory Corporation of America® Holdings (NYSE: LH) announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom (NASDAQ: SQNM) in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.
Sequenoms market-leading NIPT and genetic testing capabilities will advance LabCorps... More
